Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-19 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.3 | 5e-17 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-15 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-14 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-14 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-13 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-10 |